Induced pluripotent stem cells (iPSCs) offer hope to patients and promise to scientists due to their potential in disease pathology research and highly targeted therapies to improve health outcomes.
Our team has the core capabilities to maintain, characterize, bank, and distribute the highest quality iPSCs and our laboratories operate under the most stringent ISO 9001:2015 certified standard operating procedures, including the performance of quality control testing and assessment of pluripotency.
Below is the list of all new iPSC lines—including lines added to the NIGMS Human Genetic Cell Repository—that were added to the Coriell biobank in 2022.
| ID number | Diagnosis |
| AG28346 | Non-Wound Healing Phenotype |
| GM28374 | Neuroaxonal Dystrophy, Infantile |
| GM28227 | Neiman Pick Type C1 |
| GM28229 | Glycogen Storage Disease Type II |
| AG28369 | Non-Wound Healing Phenotype |
| AG28462 | Rothmund-Thomson Syndrome |
| GM28259 | Tay Sachs Disease |
| AG28336 | Parkinson Disease |
| GM28404 | Apparently Healthy |
| GM28383 | Scheie Syndrome |
| GM28385 | Fibrodysplasia Ossificans Progressiva |
| AG28409 | Xeroderm Pigmentosum |
| GM28558 | Alagille Syndrome 1 |
| GM27620 | Rett Syndrome, Congenital Variant (FOXG1) |
| GM28380 | Ceroid lipofuscinosis Neuronal 2, Late infantile |
| GM28559 | Alagille Syndrome 1 |
| GM27624 | Rett Syndrome, Congenital Variant (FOXG1) |
| GM28589 | Cerebral Creatine Deficiency Syndrome 3 |
| GM28622 | Glycogen Storage Disease Type II |
| AG28599 | Parkinson Disease |
| GM28399 | Neuropathy, Hereditary Sensory and Autonomic, Type III |
| GM28575 | Rett Syndrome, Congenital Variant (FOXG1) |
| GM28576 | Rett Syndrome, Congenital Variant (FOXG1) |
| GM28577 | Rett Syndrome, Congenital Variant (FOXG1) |
| GM28578 | Rett Syndrome, Congenital Variant (FOXG1) |
| AG28585 | Cockayne Syndrome Type A |
| GM28603 | Zinc-finger C4H2 Deficiency ZC4H2 |
| AG28851 | Apparently Healthy |
| AG28869 | Apparently Healthy |
| GM28862 | Leigh Syndrome |
